Clinical trial
Pamidronate Administration in Breast Cancer Patients With Bone Metastases
NCT00128297 · Spanish Breast Cancer Research Group, Other · Completed
Key facts
| NCT number | NCT00128297 |
|---|---|
| Title | Pamidronate Administration in Breast Cancer Patients With Bone Metastases |
| Official title | Randomized, Multicentric Phase IV Clinical Trial for the Administration of Pamidronate in Breast Cancer Patients With Bone Metastases |
| Lead sponsor | Spanish Breast Cancer Research Group, Other |
| Collaborators | Novartis Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Breast Cancer, Neoplasm Metastasis |
| Intervention type | Drug |
| Interventions | Pamidronate |
| Enrollment | 152 |
| Start date | Oct 18, 2000 |
| Primary completion | Jun 4, 2004 |
| Completion | Jun 4, 2004 |
| First posted | Aug 9, 2005 |
| Last update posted | Mar 28, 2023 |
| Countries | Spain |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: